BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 21432316)

  • 1. Metallothioneins and brain injury: What transgenic mice tell us.
    Hidalgo J
    Environ Health Prev Med; 2004 May; 9(3):87-94. PubMed ID: 21432316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of the metallothionein family of proteins in the central nervous system.
    Hidalgo J; Aschner M; Zatta P; Vasák M
    Brain Res Bull; 2001 May; 55(2):133-45. PubMed ID: 11470309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-6 and tumor necrosis factor-alpha type 1 receptor deficient mice reveal a role of IL-6 and TNF-alpha on brain metallothionein-I and -III regulation.
    Carrasco J; Hernandez J; Bluethmann H; Hidalgo J
    Brain Res Mol Brain Res; 1998 Jun; 57(2):221-34. PubMed ID: 9675420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the synthesis of brain metallothioneins.
    Hidalgo J; Carrasco J
    Neurotoxicology; 1998; 19(4-5):661-6. PubMed ID: 9745926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transgenic expression of interleukin 6 in the central nervous system regulates brain metallothionein-I and -III expression in mice.
    Hernández J; Molinero A; Campbell IL; Hidalgo J
    Brain Res Mol Brain Res; 1997 Aug; 48(1):125-31. PubMed ID: 9379832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metallothionein-1+2 protect the CNS after a focal brain injury.
    Giralt M; Penkowa M; Lago N; Molinero A; Hidalgo J
    Exp Neurol; 2002 Jan; 173(1):114-28. PubMed ID: 11771944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metallothionein prevents neurodegeneration and central nervous system cell death after treatment with gliotoxin 6-aminonicotinamide.
    Penkowa M; Quintana A; Carrasco J; Giralt M; Molinero A; Hidalgo J
    J Neurosci Res; 2004 Jul; 77(1):35-53. PubMed ID: 15197737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metal components analysis of metallothionein-III in the brain sections of metallothionein-I and metallothionein-II null mice exposed to mercury vapor with HPLC/ICP-MS.
    Kameo S; Nakai K; Kurokawa N; Kanehisa T; Naganuma A; Satoh H
    Anal Bioanal Chem; 2005 Apr; 381(8):1514-9. PubMed ID: 15782327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metallothioneins are upregulated in symptomatic mice with astrocyte-targeted expression of tumor necrosis factor-alpha.
    Carrasco J; Giralt M; Penkowa M; Stalder AK; Campbell IL; Hidalgo J
    Exp Neurol; 2000 May; 163(1):46-54. PubMed ID: 10785443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered central nervous system cytokine-growth factor expression profiles and angiogenesis in metallothionein-I+II deficient mice.
    Penkowa M; Carrasco J; Giralt M; Molinero A; Hernández J; Campbell IL; Hidalgo J
    J Cereb Blood Flow Metab; 2000 Aug; 20(8):1174-89. PubMed ID: 10950378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of metallothionein-3 produces changes on MT-1/2 regulation in basal conditions and alters hypothalamic-pituitary-adrenal (HPA) axis.
    Lago N; Quintana A; Carrasco J; Giralt M; Hidalgo J; Molinero A
    Neurochem Int; 2014 Jul; 74():65-73. PubMed ID: 24969724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiapoptotic effect and inhibition of ischemia/reperfusion-induced myocardial injury in metallothionein-overexpressing transgenic mice.
    Kang YJ; Li Y; Sun X; Sun X
    Am J Pathol; 2003 Oct; 163(4):1579-86. PubMed ID: 14507664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specificity and divergence in the neurobiologic effects of different metallothioneins after brain injury.
    Penkowa M; Tio L; Giralt M; Quintana A; Molinero A; Atrian S; Vasák M; Hidalgo J
    J Neurosci Res; 2006 May; 83(6):974-84. PubMed ID: 16493670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metallothionein reduces central nervous system inflammation, neurodegeneration, and cell death following kainic acid-induced epileptic seizures.
    Penkowa M; Florit S; Giralt M; Quintana A; Molinero A; Carrasco J; Hidalgo J
    J Neurosci Res; 2005 Feb; 79(4):522-34. PubMed ID: 15614785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced seizures and hippocampal neurodegeneration following kainic acid-induced seizures in metallothionein-I + II-deficient mice.
    Carrasco J; Penkowa M; Hadberg H; Molinero A; Hidalgo J
    Eur J Neurosci; 2000 Jul; 12(7):2311-22. PubMed ID: 10947810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Astrocyte-targeted expression of interleukin-3 and interferon-alpha causes region-specific changes in metallothionein expression in the brain.
    Giralt M; Carrasco J; Penkowa M; Morcillo MA; Santamaría J; Campbell IL; Hidalgo J
    Exp Neurol; 2001 Apr; 168(2):334-46. PubMed ID: 11259121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endotoxin and intracerebroventricular injection of IL-1 and IL-6 induce rat brain metallothionein-I and -II.
    Hernández J; Hidalgo J
    Neurochem Int; 1998 Apr; 32(4):369-73. PubMed ID: 9596561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The functional significance of brain metallothioneins.
    Aschner M
    FASEB J; 1996 Aug; 10(10):1129-36. PubMed ID: 8751715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of ethanol on brain metallothionein in transgenic mice.
    Suzuki Y; Cherian MG
    Alcohol Clin Exp Res; 2000 Mar; 24(3):315-21. PubMed ID: 10776668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of metallothionein-III following central nervous system damage.
    Carrasco J; Penkowa M; Giralt M; Camats J; Molinero A; Campbell IL; Palmiter RD; Hidalgo J
    Neurobiol Dis; 2003 Jun; 13(1):22-36. PubMed ID: 12758064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.